UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Pathology of non‐alcoholic fatty liver disease

Liver international, 2017-01, Vol.37 (S1), p.85-89

Bedossa, Pierre

2017

Volltextzugriff (PDF)

Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Why liver biopsy is essential

Liver international, 2018-02, Vol.38 (S1), p.64-66

Bedossa, Pierre

2018

Volltextzugriff (PDF)

Reversibility of hepatitis B virus cirrhosis after therapy: who and why?

Liver international, 2015-01, Vol.35 (s1), p.78-81

Bedossa, Pierre

2015

Volltextzugriff (PDF)

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (8), p.1811-1822.e4

2016

Volltextzugriff (PDF)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

Scientific reports, 2020-06, Vol.10 (1), p.9330-9330, Article 9330

2020

Volltextzugriff (PDF)

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Journal of hepatology, 2016-09, Vol.65 (3), p.579-588

2016

Volltextzugriff (PDF)

Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease

Scientific reports, 2020-02, Vol.10 (1), p.2565, Article 2565

2020

Volltextzugriff (PDF)

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

Hepatology (Baltimore, Md.), 2018-05, Vol.67 (5), p.2001-2012

2018

Volltextzugriff (PDF)

Improving performance of liver biopsy in fibrosis assessment

Journal of hepatology, 2014-08, Vol.61 (2), p.193-195

2014

Volltextzugriff (PDF)

Hepatocellular adenoma: Different entities for a single lesion

Annals of hepatology, 2014-07, Vol.13 (4), p.450-451

Bedossa, Pierre

2014

Volltextzugriff (PDF)

Functional role of ADAMTS5 in adiposity and metabolic health

PloS one, 2018-01, Vol.13 (1), p.e0190595-e0190595

2018

Volltextzugriff (PDF)

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

Journal of hepatology, 2015-04, Vol.62 (4), p.905-912

2015

Volltextzugriff (PDF)

Liver extracellular matrix in health and disease

The Journal of pathology, 2003-07, Vol.200 (4), p.504-515

2003

Volltextzugriff (PDF)

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Contemporary clinical trials, 2020-11, Vol.98, p.106175-106175, Article 106175

2020

Volltextzugriff (PDF)

Histological Assessment of NAFLD

Digestive Diseases and Sciences, 2016-05, Vol.61 (5), p.1348-1355

Bedossa, Pierre

2016

Volltextzugriff (PDF)

Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity

Genome Biology, 2008-01, Vol.9 (1), p.R14-R14

2008

Volltextzugriff (PDF)

Sources of variability in histological scoring of chronic viral hepatitis

Hepatology (Baltimore, Md.), 2005-02, Vol.41 (2), p.257-264

2005

Volltextzugriff (PDF)

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Histopathology, 2018-09, Vol.73 (3), p.369-385

2018

Volltextzugriff (PDF)

How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited

Clinical chemistry (Baltimore, Md.), 2008-08, Vol.54 (8), p.1372-1378

2008

Volltextzugriff (PDF)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

JHEP reports, 2019-09, Vol.1 (3), p.188-198

2019

Volltextzugriff (PDF)

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Nature communications, 2023-08, Vol.14 (1), p.5219-5219, Article 5219

2023

Volltextzugriff (PDF)

Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice

American journal of physiology: Gastrointestinal and liver physiology, 2016-10, Vol.311 (4), p.G599-G609

2016

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(340)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Pathology of non‐alcoholic fatty liver disease

Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Why liver biopsy is essential

Reversibility of hepatitis B virus cirrhosis after therapy: who and why?

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

Improving performance of liver biopsy in fibrosis assessment

Hepatocellular adenoma: Different entities for a single lesion

Functional role of ADAMTS5 in adiposity and metabolic health

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

Liver extracellular matrix in health and disease

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

Histological Assessment of NAFLD

Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity

Sources of variability in histological scoring of chronic viral hepatitis

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice

Aktive Filter

Suchergebnisse filtern